PK Samudrala, P Kumar, K Choudhary… - European journal of …, 2020 - Elsevier
Abstract SARS-CoV-2, a newly emerged pathogen in December 2019, marked as one of the highly pathogenic Coronavirus, and altogether this is the third coronavirus attack that …
V Schijns, EC Lavelle - European journal of immunology, 2020 - Wiley Online Library
The recent outbreak of coronavirus disease 2019 (COVID‐19), triggered by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) poses an enormous threat to global …
Ditengah merebaknya rencana pemerintah untuk pemberian vaksinasi Covid-19 (Sinovac) secara massal, berbagai hoax bermunculan di dalam media online, bahkan seringkali …
G Milano, J Gal, A Creisson, E Chamorey - Future Virology, 2022 - Future Medicine
While tolerance to COVID-19 vaccination is considered satisfactory, a phenomenon of myocarditis, although rare, is becoming a safety concern in mRNA COVID-19 vaccination …
COVID-19 vaccines have been instrumental tools in reducing the impact of SARS-CoV-2 infections around the world by preventing 80% to 90% of hospitalizations and deaths from …
L Lee, GM Peterson, M Naunton, S Jackson, M Bushell - Pharmacy, 2020 - mdpi.com
Background: The COVID-19 pandemic is ongoing. The unprecedented challenges worldwide implore the urgent development of a safe and effective COVID-19 vaccine …
LV Kordyukova, AV Shanko - Biochemistry (Moscow), 2021 - Springer
COVID‑19, a new human respiratory disease that has killed nearly 3 million people in a year since the start of the pandemic, is a global public health challenge. Its infectious agent …
The variety of available biocidal features make nanomaterials promising for fighting infections. To effectively battle COVID-19, categorized as a pandemic by the World Health …
RS Shapiro - International journal of dermatology, 2021 - Wiley Online Library
Background The COVID‐19 virus‐induced pandemic has been the deadliest pandemic to have occurred in two generations, besides HIV/AIDS. Epidemiologists predicted that the …